According to the new market research report According to the new market research report “Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region – Global Forecast to 2025“, published by MarketsandMarkets™, global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%.

Browse and in-depth TOC on “Primary Cells Market”

108 – Tables
34 – Figures
179 – Pages

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

Major Growth Drivers:

Market growth is driven by the rising prevalence of cancer, increasing cancer research, rising investments in regenerative medicine research, rising demand for monoclonal antibodies, and rapid growth in the biotechnology and biopharmaceutical industries.

Expected Revenue Growth:

[179 Pages Report] The global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%.

COVID-19 Impact on Global Primary Cells Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (CHINA) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.

Based on origin, the primary cells market is segmented into human and animal primary cells. The human primary cells segment accounted for the largest share in the primary cells market in 2019. The increasing adoption of human primary cells in developing novel cancer therapies and the rising funding for the R&D for cell therapies are the major factors driving the growth of this segment.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960

“North America is the largest regional market for primary cells”

The global primary cells market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the primary cells market. The growth in the North American primary cells market can be attributed to the increasing number of players launching new human primary cells for research, expansion of the pharmaceutical and biotechnology industries, growing focus on R&D, and increasing prevalence of cancer in the region.

According to the new market research report According to the new market research report “Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region – Global Forecast to 2025“, published by MarketsandMarkets™, global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%.

Browse and in-depth TOC on “Primary Cells Market”

108 – Tables
34 – Figures
179 – Pages

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

Major Growth Drivers:

Market growth is driven by the rising prevalence of cancer, increasing cancer research, rising investments in regenerative medicine research, rising demand for monoclonal antibodies, and rapid growth in the biotechnology and biopharmaceutical industries.

Expected Revenue Growth:

[179 Pages Report] The global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%.

COVID-19 Impact on Global Primary Cells Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (CHINA) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.

Based on origin, the primary cells market is segmented into human and animal primary cells. The human primary cells segment accounted for the largest share in the primary cells market in 2019. The increasing adoption of human primary cells in developing novel cancer therapies and the rising funding for the R&D for cell therapies are the major factors driving the growth of this segment.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960

“North America is the largest regional market for primary cells”

The global primary cells market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the primary cells market. The growth in the North American primary cells market can be attributed to the increasing number of players launching new human primary cells for research, expansion of the pharmaceutical and biotechnology industries, growing focus on R&D, and increasing prevalence of cancer in the region.

Primary Cells Market Size, Share, Emerging Trends with Forecast till 2023

According to Market Research Future (MRFR), the global primary cells market is expected to garner a higher single-digit growth by the end of the review period of 2023. In its recently published analysis, MRFR also asserts that the global primary cells market would register a CAGR of over 9.5% over the assessment period (2018-2023).

Leading Market Players

STEMCELL Technologies (Canada), Promocell (Germany), Lonza (Switzerland), Merck KGaA (Germany), Cell Biologics (US), Axol Biosciences (UK),ZenBio, Inc. (US), ALLCells (US), Thermo Fisher Scientific (US), American Type Culture Collection (ATCC) (US), among others.

Primary cells are human cells directly obtained and cultured from their source and have better replication properties than secondary cell lines. The primary cells market is expected to gain an upward trajectory owing to the explosive growth of end-users such as biopharmaceutical industries, research centers, and others.

Global Primary Cells Market – Segments

By Origin              : Skin Cells, Hematopoietic Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart, Skeletal and Muscle Cells, and Others.

By Type : Human Primary Cells and Animal Primary Cells.

By End-use         : Research Institutes and Life Science Research Companies.

By Regions   : Europe, North America, Asia Pacific, and the Rest-of-the-World.

Key Questions Answered in This Report:

• What will the market size and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

The competitive landscape in the sector is not limited to companies alone and also involves nations. Nations are pursuing overseas investment strategies to develop their own biotech sector. For example, Chinese overseas investment in the biotechnology sector has grown rapidly and in 2018, the top recipient of Chinese investment in the US, was biotech in the form of acquisitions.

Global Primary Cells Market Research Report: By Origin (Hematopoietic Cells, Skin Cells, Liver Cells, Heart, Other), By Type (Human Primary Cells, Animal Primary Cells), By End-User (Research Institute, Life Science Research Companies) -–Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/primary-cells-market-6296

Table Of Content

1. REPORT PROLOGUE
2. MARKET INTRODUCTION

2.1.         Definition

2.2.         Scope of the Study

2.2.1.     Research Objective

2.2.2.     Assumptions

2.2.3.     Limitations         

1. RESEARCH METHODOLOGY

3.1.         Overview

3.2.         Primary Research

3.3.         Secondary Research

3.4.         Market Size Estimation

1. MARKET DYNAMICS

4.1.         Overview

4.2.         Drivers

4.3.         Restraints

4.4.         Opportunities

Continued….

Browse Other Healthcare Related Reports

Population Health Management Market – Global Forecast 2018 – 2023

Vocal Biomarkers Market – Global Forecast 2017 – 2023

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

https://www.marketresearchfuture.com/

The drug screening market is expected to reach USD 8.63 Billion by 2022 from USD 5.32 Billion in 2017, at a CAGR of 10.2%.

Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the availability of government funding in major markets are driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Drug screening market segmentation:

• based on products
• based on diseases
• based on techniques,
• based on end users
• based on regions.

The Major Players Opearting in the Drug screening Market:

Most key players adopted product launches as the primary growth strategy between 2014 and 2017. Some of the companies that adopted this strategy include Alfa Scientific Designs, Thermo Fisher, and Premier Biotech

.

Geographical Detailed Analysis for Drug screening Market:

North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as growing consumption of illicit drugs, the availability of government funding to curb drug addiction, presence of laws supporting drug screening, and growing burden of road accidents due to alcohol consumption in the region.

The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Alere (US), Thermo Fisher (US), Siemens Healthineers (Germany), Alfa Scientific Designs (US), Roche (Switzerland), MPD, Inc. (US), Shimadzu (Japan), OraSure (US), Lifeloc (US), and Drägerwerk (Germany). On the other hand, LabCorp (US), Quest Diagnostics (US), Psychemedics (US), Omega Laboratories (US), CRL (US), SureHire (Canada), and CannAmm (Canada).

Read More in Detailed (Drug screening Market ):

https://www.marketsandmarkets.com/PressReleases/drug-alcohol-screening.asp